LivaNova (LIVN) Assets Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.66% |
| Dec 31, 2025 | 3.98% |
| Sep 30, 2025 | 1.41% |
| Jun 30, 2025 | 193.15% |
| Mar 31, 2025 | 4.03% |
| Dec 31, 2024 | 3.16% |
| Sep 30, 2024 | 8.27% |
| Jun 30, 2024 | -63.48% |
| Mar 31, 2024 | 7.18% |
| Dec 31, 2023 | 5.87% |
| Sep 30, 2023 | 5.27% |
| Jun 30, 2023 | 0.23% |
| Mar 31, 2023 | -5.05% |
| Dec 31, 2022 | 4.26% |
| Sep 30, 2022 | 0.43% |
| Jun 30, 2022 | -2.52% |
| Mar 31, 2022 | 2.01% |
| Dec 31, 2021 | -8.29% |
| Sep 30, 2021 | -12.62% |
| Jun 30, 2021 | -4.24% |
| Mar 31, 2021 | -3.47% |
| Dec 31, 2020 | -0.49% |
| Sep 30, 2020 | 0.47% |
| Jun 30, 2020 | -4.54% |
| Mar 31, 2020 | -5.58% |
| Dec 31, 2019 | -5.41% |
| Sep 30, 2019 | -3.86% |
| Jun 30, 2019 | 0.94% |
| Mar 31, 2019 | -3.89% |
| Dec 31, 2018 | 1.83% |
| Sep 30, 2018 | 0.29% |
| Jun 30, 2018 | 2.50% |
| Mar 31, 2018 | 14.10% |
| Dec 31, 2017 | 6.88% |
| Sep 30, 2017 | 4.25% |
| Jun 30, 2017 | 0.35% |
| Mar 31, 2017 | -9.44% |
| Dec 31, 2016 | -8.45% |